Publications
Singh B, Tai K, Madan S, Raythatha MR, Cady AM, Braunlin M, Irving LR, Bajaj A, Lucci A. Selection of metastatic breast cancer cells based on adaptability of their metabolic state. PLoS ONE 2012;7:e36510. doi: 10.1371/journal.pone.0036510.
Singh B, Shamsnia A, Raythatha MR, Milligan RD, Cady AM, Madan S, Lucci A. Highly adaptable triple-negative breast cancer cells as a functional model for testing anticancer agents. PLoS ONE 2014;9:e109487. doi: 10.1371/journal.pone.0109487.
Singh B, Kinne HE, Milligan RD, Washburn LJ, Olsen M, Lucci A. Important role of FTO in the survival of rare panresistant triple-negative Inflammatory Breast Cancer cells facing a severe metabolic challenge. PLoS ONE 2016;11:e0159072. doi: 10.1371/journal.pone.0159072.
Singh B, Sarli VN, Washburn LJ, Raythatha MR, Lucci A. A usable model of "decathlon winner" cancer cells in triple-negative breast cancer: survival of resistant cancer cells in quiescence. Oncotarget 2018;9:11071-82. doi: 10.18632/oncotarget.24322.
Krishnamurthy S, Cristofanilli M, Singh B, Reuben J, Gao H, Cohen EN, Andreopoulou E, Hall CS, Lodhi A, Jackson S, Lucci A. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer 116(14):3330-7, 7/2010. PMID: 20564098.
Hall C, Krishnamurthy S, Lodhi A, Mosalpuria K, Kuerer HM, Meric-Bernstam F, Bedrosian I, Hunt KK, Lucci A. Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. Ann Surg Oncol 17(12):3252-8, 12/2010. e-Pub 6/2010. PMID: 20559739.
Hall C, Lucci A. How heterogeneous cell populations, cancer cell dormancy, and minimal residual disease influence the natural history of cancers. Oncology (Williston Park) 25(1):47, 50, 1/2011. PMID: 21361243.
Hall C, Krishnamurthy S, Lodhi A, Bhattacharyya A, Anderson A, Kuerer H, Bedrosian I, Singh B, Lucci A. Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer. Cancer 118(2):342-8, 1/2012. e-Pub 6/2011. PMID: 21717428.
Lucci A, Hall CS, Lodhi AK, Bhattacharyya A, Anderson AE, Xiao L, Bedrosian I, Kuerer HM, Krishnamurthy S. Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 13(7):688-95, 7/2012. e-Pub 6/2012. PMID: 22677156.
Krishnamurthy S, Bischoff F, Ann Mayer J, Wong K, Pham T, Kuerer H, Lodhi A, Bhattacharyya A, Hall C, Lucci A. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer. Cancer Med 2(2):226-33, 4/2013. e-Pub 3/2013. PMCID: PMC3639661.
Karhade M, Hall C, Mishra P, Anderson A, Kuerer H, Bedrosian I, Krishnamurthy S, Lucci A. Circulating tumor cells in non-metastatic triple-negative breast cancer. Breast Cancer Res Treat 147(2):325-33, 9/2014. e-Pub 8/2014. PMCID: PMC4149877.
Mosalpuria K, Hall C, Krishnamurthy S, Lodhi A, Hallman DM, Baraniuk MS, Bhattacharyya A, Lucci A. Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients. Mol Clin Oncol 2(5):845-850, 9/2014. e-Pub 6/2014. PMCID: PMC4106732.
Hall CS, Karhade M, Laubacher B, Anderson A, Kuerer HK, DeSnyder S, Lucci A. Circulating tumor cells after neoadjuvant chemotherapy in stage I-III triple negative breast cancer. Ann Surg Oncol. 2015 May 13. PMID:25968619
Roland CL, Ross MI, Hall CS, Laubacher B, Upshaw J, Anderson A, Lucci A. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study. Melanoma Res. 2015 May 14. PMID: 26011119
Hall CS, Karhade M, Laubacher BA, Kuerer HM, Krishnamurthy S, DeSnyder S, Anderson AE, Valero V, Ueno NT, Li Y, Su X, Lucci A. Circulating Tumor Cells and Recurrence after Primary Systemic Therapy in Stage III inflammatory Breast Cancer. J Natl Cancer Inst. 2015 Sep 14;107(11). PMID:26374427.
Janni W, Rack B, Terstappen LW, Pierga JY, Taran FA, Fehm T, Hall C, de Groot M, Bidard FC, Friedl TW, Fasching PA, Brucker SY, Pantel K, Lucci A. Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer. Clin Cancer Res. 2016 May 15;22(10):2583-93. PMID: 26733614
Hall CS, Karhade MG, Bowman Bauldry JB, Valad LM, Kuerer HM, DeSnyder SM, Lucci A. Prognostic Value of Circulating Tumor Cells Identified Before Surgical Resection in Nonmetastatic Breast Cancer Patients. J Am Coll Surg. 2016 Jul;223(1):20-9. PMID: 27049782
Fayanju OM, Hall CS, Bauldry JB, Karhade M, Valad LM, Kuerer HM, DeSynder SM, Barcenas CH, Lucci A. Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer. Am J Surg. 2017 Oct;214(4):666-671. PMID: 28720217
Bidard FC, Michiels S, Reithdorf S, et al. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. J Natl Cancer Inst. 2018 Jun1;110(6):560-567. PMID: 29659933
Hall CS, Ross M, Bowman Bauldry JB, Upshaw J, Karhade M, Royal R, Patel S, Lucci A. Circulating Tumor Cells in Stage IV Melanoma Patients. J Am Coll Surg. 2018 Jul;227(1):116-124. PMID: 29746918